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Abstract
Background: Lentiviral vectors hold great promise as gene transfer vectors in gene therapeutic
settings. However, problems related to the risk of insertional mutagenesis, transgene silencing and
positional effects have stalled the use of such vectors in the clinic. Chromatin insulators are
boundary elements that can prevent enhancer-promoter interactions, if placed between these
elements, and protect transgene cassettes from silencing and positional effects. It has been
suggested that insulators can improve the safety and performance of lentiviral vectors. Therefore
insulators have been incorporated into lentiviral vectors in order to enhance their safety profile
and improve transgene expression. Commonly such insulator vectors are produced at lower titers
than control vectors thus limiting their potential use.
Results: In this study we cloned in tandem copies of the chicken β-globin insulator (cHS4) on both
sides of the transgene cassette in order to enhance the insulating effect. Our insulator vectors were
produced at significantly lower titers compared to control vectors, and we show that this reduction
in titer is due to a block during the transduction process that appears after reverse transcription
but before integration of the viral DNA. This non-integrated viral DNA could be detected by PCR
and, importantly, prevented efficient transduction of target cells.
Conclusion: These results have importance for the future use of insulator sequences in lentiviral
vectors and might limit the use of insulators in vectors for in vivo use. Therefore, a careful analysis
of the optimal design must be performed before insulators are included into clinical lentiviral
vectors.
Background
Lentiviruses are complex retroviruses that are capable of
infecting non-dividing cells[1,2]. As a consequence lenti-
viral vectors, such as those based on HIV-1, efficiently
transduce a variety of cell types including embryonic stem
cells, haematopoietic cells and neurons, and have been
suggested as candidate vectors for both in vivo and ex vivo
gene therapy applications [3-5]. A key step in the retroviral
life-cycle is integration of the provirus into the host
genome. This integrating nature of retroviruses has been
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exploited in the development of gene transfer vectors and
has been deemed essential for certain gene therapy strate-
gies, including ex vivo gene transfer[6,7]. However,
adverse issues related to the integration of a provirus such
as insertional mutagenesis, promoter interference and
positional effects have been highlighted by induction of
malignancy in mouse models[8] and by the development
of leukaemia in five patients in two clinical gene therapy
trials[9,10]. Consequently, obtaining adequate safety and
efficiency of viral vectors is a focus of interest in vector
development.
Insertion of chromatin insulator elements into the vector
sequence has been proposed as a solution to problems
related to the integration of proviruses[11]. An insulator is
a cis-acting element characterized by one or both of the
following criteria: it prevents enhancer-promoter interac-
tions, if placed in between these elements, and protects
transgenic expression cassettes from silencing and posi-
tional effects[11,12]. Hence, if these characteristics could
be transferred to a lentiviral vector it would confer protec-
tion from influences of the integrated viral sequence to
surrounding endogenous genes, and since it may prevent
silencing of a proportion of the proviruses, it may also
enhance vector functionality allowing a lower number of
integrants to be used in order to achieve therapeutic effi-
cacy. Taken together, such improvements of the vector
properties would be likely to reduce the risk related to the
proviral integration[13].
However, before insulators are included into clinical gene
therapy vectors, a number of issues remain to be clarified.
So far, no studies have clearly demonstrated an enhanced
safety of insulator vectors, although it has recently been
shown that inclusion of insulators in lentiviral vectors
suppresses clonal dominance in vitro and partially protects
against genotoxicity and promoter interference [14-17].
Furthermore, improved transgene expression from insula-
tor containing retro- and lentiviral vectors has been
reported predominantly in cell lines of erythroid origin
and appears to be cell-type dependent [18-20]. Finally,
the inclusion of insulator-sequences has been reported to
reduce the titer of viral vector preparations, which compli-
cates transduction of difficult target cells or direct in vivo
applications[19,21,22].
In this study we addressed some of the issues of lentiviral
vectors carrying chromatin insulators. For this we
designed a set of insulator-lentiviral vectors that were
tested in cells of different lineages. We found that lentivi-
ral vectors are indeed capable of incorporating insulator
sequences leading to efficient transgene expression in dif-
ferent cell types. However, a careful examination of their
functionality suggests that the titer is compromised at a
step that takes place after reverse transcription but before
proviral integration. This finding has implications for the
design of insulator-containing lentiviral vectors and high-
lights the importance of extensive studies of vector func-
tionality following inclusion of cis-acting elements.
Results
Lentiviral vectors
We constructed second generation HIV-1 derived lentivi-
ral vectors with the chicken β-globin insulator (cHS4) in
various configurations (Figure 1). All vectors carried the
central polypurine tract (cPPT) and the woodchuck hepa-
titis post-transcriptional regulatory element (WPRE),
which have been shown to enhance the functionality of
lentiviral vectors[23,24]. We used two promoters, the
human cytomegalovirus promoter (CMV) and the human
elongation factor 1α promoter (EF1α), in order to avoid
misinterpretation of the results due to possible promoter-
specific events. The first design of the insulator vectors had
tandem copies of the 250 bp core element[25] placed just
upstream of the expression cassette (s2 × 250 bp.CMV, fig-
ure 1B). The second design had a second doublet of the
250 bp core element placed just after the transcriptional
cassette (d2 × 250 bp, figure 1C and 1F). We also used our
previously reported vector, which carries the full length
1.2 kb insulator into the 3'LTR (1.2 kb.CMV, figure
1D)[21]. This design leads to a duplication of the insula-
tor sequence into the 5' LTR during reverse transcription.
As control vectors we used CMV.SIN and EF1α.SIN (Fig-
ure 1A and 1E).
Titers of insulator-containing vectors are reduced
Previously, we and others have suggested that the func-
tional titer is reduced when insulator sequences are incor-
porated into retroviral and lentiviral vectors[19,21,22].
Therefore, we decided to estimate vector titer in two inde-
pendent ways. The functional titer was estimated by trans-
ducing 293T cells with limited dilutions of vector stocks.
The proportion of GFP expressing cells was then estimated
and transductions containing around 10% GFP express-
ing cells were used to calculate a functional titer. A relative
DNA titer was measured by quantifying the level of viral
DNA relative to endogenous genomic DNA by performing
real-time PCR on DNA from transduced 293T cells.
The vector carrying a single copy of the 2 × 250 bp doublet
(s2 × 250 bp.CMV) was produced at a similar functional
titer as the control vectors (CMV.SIN and EF1α.SIN)
(Table 1). However, the titer of our vector carrying the 1.2
kb (1.2 kb.CMV) insulator in the LTR was significantly
reduced (P < 0.01) more than 6-fold (average: 4.9 × 107
TU/ml, 1.2 kb.CMV vector vs. 3.0 × 108 TU/ml, CMV.SIN)
which is in agreement with what we have reported previ-
ously with a similar design lacking the cPPT[21]. In addi-
tion, the functional titer of the CMV vector carrying
double copies of the 2 × 250 bp element (d2 × 250BMC Biotechnology 2009, 9:13 http://www.biomedcentral.com/1472-6750/9/13
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bp.CMV) was significantly (P < 0.01) reduced almost 20-
fold (average 1.6 × 107 TU/ml) compared to the control
vector (CMV.SIN). The same was true for the d2 × 250
bp.EF1α vector where the functional titer was reduced
almost 28-fold (1.4*107TU/ml of d2 × 250 bp.EF1α vs.
3.9*108  of EF1α.SIN). Interestingly, such a dramatic
reduction in the relative DNA titer could not be observed,
where only the titer of d2 × 250 bp.EF1α was significantly
reduced (4-fold, 9.0*107TU/ml of d2 × 250 bp.EF1α vs.
3.9*108 of EF1α.SIN).
In order to analyse if the discrepancy between functional
titer and relative DNA titer of d2 × 250 bp and 1.2 kb.CMV
vectors was due to loss of the transcriptional cassette by
homologous recombination during the transduction
process, we transduced 293T cells with the four vectors
carrying the CMV promoter (Figure 1A–D). DNA was har-
vested at 28 days post-transduction, and real-time PCR
was performed using four sets of primers (LV2-, GFP-,
WPRE- and INS-primers, see figure 1 for primer location)
to determine the abundance of each of the different
sequences in relation to each other. The LV2-primer was
used as reference. At this late time-point post transduction
Outline of lentiviral vectors Figure 1
Outline of lentiviral vectors. Schematic drawing of vectors used in this study. Vectors A-D utilize the CMV-promoter 
whereas vectors E-F use the EF1α-promoter. (A, E) Control vectors for the group of CMV and EF1α vectors respectively. 
Cloning sites for the cis-elements are shown. (B) One tandem repeat (2 × 250) of the core element of chicken β-globin insula-
tor (cHS4) was inserted (sense orientation) prior to the promoter. (C, F) Two copies of the tandem repeat were inserted into 
the vectors – one just upstream the promoter and one just downstream the expression cassette. (D) The entire cHS4-insula-
tor (1.2 kb) was inserted in the 3' LTR in sense orientation. (A-F) Horizontal lines denote the location of primers (labelled LV2, 
GFP, WPRE and INS) used for quantitative real-time PCR (qPCR). Legend: LTR – Long Terminal Repeat, ψ – packaging signal, 
RRE – Rev Responsive Element, cPPT – Central Poly Purine Tract, CMV – Cytomegalo virus promoter, EF1α – Elongation Fac-
tor 1α promoter, GFP – Green Fluorescent Protein, WPRE – Woodchuck Posttranscriptional Regulatory Element, 2 × 250 – 
tandem repeat of the cHS4 core element and 1.2 kb – full length cHS4 insulator sequence.
A CMV.SIN B s2x250bp.CMV
2x250
RRE CMV GFP WPRE 3’ LTR cPPT ψ 5’ LTR
LV2 GFP WPRE
RRE CMV GFP WPRE 3’ LTR cPPT ψ
LV2 GFP WPRE
5’ LTR
ClaI KpnI
EE F 1 α.SIN F d2x250bp.EF1α
RRE EF1α GFP WPRE 3’ LTR cPPT ψ
LV2 GFP WPRE
5’ LTR
ClaI KpnI
RRE EF1α GFP WPRE 3’ LTR cPPT ψ
LV2 GFP WPRE
5’ LTR
2x250 2x250
1.2kb INS
RRE CMV GFP WPRE 3’ LTR cPPT ψ 5’ LTR
LV2 GFP WPRE
C d2x250bp.CMV D 1.2kb.CMV
LV2 GFP WPRE 2x250
RRE CMV GFP WPRE 3’ LTR cPPT ψ 5’ LTR
2x250
Table 1: Titer of viral batches
Vector Functional titer
*108 TU/ml
Relative DNA titer *108 U/ml
CMV.SIN 3.0 ± 0.4 N/A
s2 × 250.CMV 1.2 ± 0.5 1.6 ± 0.05
d2 × 250.CMV 0.16 ± 0.05 * 0.62 ± 0.05
1.2 kb.CMV 0.49 ± 0.08 * 1.2 ± 0.3
EF1α.SIN 3.9 ± 0.9 N/A
d2 × 250.EF1α 0.14 ± 0.02 * 0.9 ± 0.2 *
Functional and relative DNA titer of viral vectors (mean ± SEM). CMV.SIN and EF1α.SIN work as references for each group of vectors. By 
definition the relative DNA titers of the control vectors (CMV.SIN and EF1α.SIN) are identical to their respective functional titers. * denotes 
significant (P < 0.05) different titer compared to the vector's respective control.BMC Biotechnology 2009, 9:13 http://www.biomedcentral.com/1472-6750/9/13
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we expected that potential episome-like structures would
be diluted out due to cell division and that only properly
integrated viral sequences would contribute to the real-
time PCR readings. We found an approximate 1:1-ratio
between LV2-, GFP- and WPRE-sequences in all vectors
but the one carrying two copies of the insulator doublet
(d2 × 250 bp.CMV vector, Table 2). The latter showed a
significant (P < 0.001) decrease in the abundance of the
GFP-sequence when compared to the control vector (0.69
± 0.02, d2 × 250 bp.CMV vs. 1.15 ± 0.05, CMV.SIN, rela-
tive units) along with an insignificant tendency that also
the WPRE-sequence was underrepresented (0.88 ± 0.08,
d2 × 250 bp vs. 1.25 ± 0.09, CMV.SIN, relative units). This
suggests that only the d2 × 250 bp vector loses the tran-
scriptional cassette during transduction but that this hap-
pens only in a minority of integrants. Such
rearrangements are common in recombinant retroviral
vectors with direct repeats[26,27], and our data suggest
that the same might be true for some configurations of
direct repeats in lentiviral vectors. However, as only a
minority of the d2 × 250 bp.CMV integrants seems to have
undergone rearrangements and since the other three vec-
tors, including the 1.2 kb.CMV vector, were integrated in
a proper configuration, rearrangements followed by loss
of the transcriptional cassette do not seem to explain the
discrepancy between the functional titer and the relative
DNA titer. Finally, we found that the ratio between the
QPCR readings of LV2 and INS was approximately 1:2
after transduction with the 1.2 kb.CMV vector compared
to 1:1 in plasmid DNA (Table 2), showing that the full
length 1.2 kb insulator is efficiently duplicated during
reverse transcription.
In summary, the two different ways of titration and the
analysis of possible vector rearrangement suggest that the
vectors containing two separated copies of the insulator in
the reversed transcribed form (d2 × 250 bp.EF1α, d2 ×
250 bp.CMV and 1.2 kb.CMV) are fully functional and
that the transgene expression from these vectors appears
to be reduced compared to control vectors (EF1α.SIN,
CMV.SIN and s2 × 250 bp.CMV).
Transgene expression
To determine the influence of the insulator elements on
transgene expression three different cell-types of different
lineages were transduced with the lentiviral vectors at a
multiplicity of infection (MOI) of 1 and 5 based on the
relative DNA titer. The use of the relative DNA titer, which
is not based on transgene expression capability during
titration, allows comparison between different vector
designs. For these experiments we used human 293T cells,
which are derived from embryonic kidney, RN33B, which
are immortalized rat neural precursor cells, and K562,
which are human erythroid progenitor cells. The trans-
duced cells were passaged for 7 days and then transgene
expression (GFP) was determined by flow cytometry. The
neural stem cell line, RN33B, was in a separate experiment
also differentiated in vitro for 7 days.
When transducing the cell lines with the d2 × 250 bp vec-
tors, we found less GPF-positive cells and lower mean flu-
orescence (mean fluorescence units – MFU) independent
of cell type and promoter choice when comparing with
control vectors (Figure 2A–Q), which suggests that the
cHS4 core element fails to increase transgene expression.
In addition, the insulator was unable to prevent transgene
silencing during differentiation of RN33B cells (results
not shown). This is in agreement with recent results show-
ing that the 250 bp core element of the cHS4-insulator is
insufficient for insulating properties in a retroviral and
lentiviral context[15,28]. Surprisingly, however, QPCR
analyses of the proviral load in transduced cell cultures
revealed significantly lower levels of viral DNA in cultures
transduced with the d2 × 250 bp vectors compared to con-
trol vectors (Figure 2, C, H, K and 2N), despite the fact that
we had normalized the various transductions using the
Table 2: Integrity of proviral integrants
Vector LV2 primers (Reference) Relative measurement
GFP primers
Relative measurement
WPRE primers
Relative measurement
INS primers
CMV.SIN 1 1.15 ± 0.05 1.25 ± 0.09 -
s2 × 250 bp.CMV 1 1.11 ± 0.02 1.39 ± 0.14 -
d2 × 250 bp.CMV 1 0.69 ± 0.02 * 0.88 ± 0.08 -
1.2 kb.CMV 1 1.20 ± 0.05 1.21 ± 0.29 2.23 ± 0.04 *
1.2 kb.CMV (Plasmid) 1 - - 0.98 ± 0.03
Real-time PCR data showing the abundance of four sequences (see figure 1 for primer location) present in the viral vectors. 293T cells were 
transduced at MOI 1 (functional titer) and after 28 days cells were harvested and analysed. Abundance of sequences detected with primer pairs 
GFP, WPRE and INS was calculated using LV2 primers as reference. For CMV.SIN and s2 × 250 bp.CMV the ratio between LV2, GFP and WPRE 
was approximately 1:1:1 as expected. With respect to the d2 × 250 bp.CMV vector the ratio was roughly 1:0.7:0.9, which indicate that the GFP 
sequence is less abundant in cell cultures transduced with this vector (P < 0.001). This suggests that the vector undergoes some degree of 
rearrangement during production, reverse transcription or integration. In contrast, the 1.2 kb.CMV vector did not show any sign of 
rearrangements, as the ratio of LV2, GFP, WPRE and INS was approximately 1:1:1:2 when measuring on genomic DNA of transduced cells. In 
addition, the ratio between LV2 and INS was 1:1 when measuring on 1.2 kb.CMV plasmid DNA as expected. Significance is denoted by *.BMC Biotechnology 2009, 9:13 http://www.biomedcentral.com/1472-6750/9/13
Page 5 of 12
(page number not for citation purposes)
Expression data of the d2 × 250 bp vectors Figure 2
Expression data of the d2 × 250 bp vectors. Flow cytometric data and corresponding determination of proviral load for 
d2 × 250 vectors in three different cell types: RN33B (naïve) (A-E), 293T (F-K) and K562 (L-Q). Cells were transduced at MOI 
1 and 5 (relative DNA titer) and analysed 7 days after transduction. The figure shows the percentage of GFP positive cells for 
each vector (A, D, F, I, L and O) along with the corresponding mean fluorescence (MFU) (B, E, G, J, M and P) and proviral load 
(the latter only for selected vectors) (C, H, K, N and Q). Error bars denote standard deviations.
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relative DNA titer. This difference in viral DNA accounted
for most of the difference in transgene expression. This is
surprising since we have previously used the relative DNA
titer for titer determination of vectors with another com-
monly used cis-element, the scaffold attachment region
(SAR)[19,29], and subsequently found complete agree-
ment between the proviral loads of cell cultures trans-
duced with the vector containing this cis-element and the
control vector (supplementary information (Additional
file 1 and 2: Supplementary information.pdf and Supple-
mentary tables.pdf)). In addition, these data confirm that
the negative effects on vector functionality observed when
inserting the 2 × 250 bp doublet after the WPRE are not
caused by the size increment of the vector, since the inser-
tion of the SAR element, which is similar in size compared
to the 2 × 250 bp doublet, in this position does not influ-
ence the functional titer, the relative DNA titer, transgene
expression levels or proviral loads of transduced cultures.
Thus the reduced transgene expression from the d2 × 250
bp vectors probably reflects impaired vector functionality
with regard to cell entry, integration etc, and this might
explain the observed discrepancies between the functional
titer and the relative DNA titer.
Double copies of insulators result in less proviral integrants
One explanation of the overestimation of titer when using
relative DNA titration of the d2 × 250 bp and 1.2 kb.CMV
vectors could be that these configurations of insulator
sequences have a deleterious effect on vector functionality
at a stage after reverse transcription (i.e. viral integration).
Using real-time PCR to quantify viral DNA detects not
only viral DNA that is properly integrated but also viral
DNA that remains non-integrated. If such non-integrated
viral DNA was abundant in cell cultures transduced with
the d2 × 250 bp and the 1.2 kb.CMV vectors, titer determi-
nation using real-time PCR 3 days after transduction
would overestimate the titers, compared to titer determi-
nation conducted 7 days post-transduction, where non-
integrated viral DNA will be more diluted due to ongoing
cell division. In this study titer determination was per-
formed 3 days post transduction where all viral integra-
tion has normally occurred[30], whereas viral DNA levels
in the expression analyses were measured 7 days post
transduction. A similar overestimation of the functional
titer is unlikely to happen if the non-integrated viral DNA
is present in a form not suitable for transgene expression,
since only properly integrated and transgene expressing
vector genomes will contribute to this titer determination.
These circumstances could explain the inconsistent rela-
tionship between the relative and the functional titer and
the proviral loads measured in the expression analyses of
the d2 × 250 bp and the 1.2 kb.CMV vectors.
To test this hypothesis we transduced 293T cells at MOI 1
(based on functional titer) with the four CMV vectors.
Cells were passaged and part of each cell culture was har-
vested at days 3, 6, 14 and 27. Real-time PCR (using prim-
ers LV2 and ALB) on DNA isolated from these cells
revealed that the proviral load was significantly (P <
0.001) decreased in cells transduced with the d2 × 250 bp
vector and the 1.2 kb vector during day 3–6 (on day six the
proviral loads of the d2 × 250 bp vector and the 1.2 kb
vectors were 28% ± 10% and 37% ± 16%, respectively, of
their initial proviral loads measured on day three) (Figure
3). After the initial drop the proviral load stayed a con-
stant low level for at least 27 days (only 3, 6 and 14 days
time points are shown in the figure). In vectors containing
none or only one insulator-doublet in the reverse tran-
scribed form (CMV.SIN and s2 × 250 bp.CMV) no such
drop was observed (Figure 3). These results support the
hypothesis that lentiviral vectors carrying two separated
copies of the cHS4 insulator in the reverse transcribed
form are capable of efficient cell-entry and subsequent
reverse transcription (since high levels of viral DNA can be
detected 3 days post transduction), but that the transduc-
tion process is impaired at some step after reverse tran-
scription but before integration (since the abundance of
viral DNA declines during day 3–6 post transduction).
Notably, the insulator sequence itself is not deleterious to
the vector since we could not detect any decrease in viral
load of the s2 × 250 bp.CMV vector from day 3 to 6 (Fig-
ure 3). The same was true for our vector containing the
SAR element confirming that loss of viral DNA from day
3–6 was not attributable to the size increment of the d2 ×
250 bp vector (supplementary figure 3 (Additional file 3:
Persistence of viral DNA in transduced cells during a 14 day  time period Figure 3
Persistence of viral DNA in transduced cells during a 
14 day time period. 293T cells were transduced at MOI 1 
(relative DNA titer) with the four vectors utilizing the CMV-
promoter. After 3, 6, 14 and 27 days cells were harvested 
and the proviral load determined by qPCR using primers LV2 
and ALB. The vectors containing two separated copies of the 
insulator (d2 × 250 bp.CMV and 1.2 kb.CMV) elicit a signifi-
cant (*, p < 0.05) drop in proviral load within the first 6 days 
after transduction compared to control vectors, CMV.SIN 
and s2 × 250 bp.CMV. The experiment was continued for 27 
days with no change in proviral load compared to the 14 days 
time point. Error bars denote standard error of the mean.
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Supplementary figures.pdf)). It is possible that two iden-
tical insulator sequences separated by an appropriate
spacing as in the d2 × 250 bp.CMV vector and the reversed
transcribed form of the 1.2 kb.CMV vector induce the for-
mation of secondary structure incompatible with proper
transduction and transgene expression.
Non-integrating vectors prevent efficient transduction
Our results with the d2 × 250 bp vectors suggest that the
low titer is due to several independent defects. As shown
above, a large proportion of the vectors are unable to inte-
grate and express the transgene. Furthermore, a minor
proportion of the vectors that integrate will have lost the
transgene cassette due to vector rearrangements. However,
it is worth pointing out that in contrast to oncoretroviral
vectors with a similar design functional particles are pro-
duced[22].
To test the transduction potential of these remaining func-
tional vectors, we transduced RN33B cells at an MOI of 1
and 5, this time based on the functional titers. At 7 days
after transduction cells were harvested and flow cytometry
performed. For the CMV vectors at a MOI of 1, the d2 ×
250 bp vector seemed to perform as well as the control
vector (Figure 4A and 4B). However, at high MOI, the d2
× 250 bp vector expressed GFP at a much lower level than
the control vector (Figure 4A and 4B). When using EF1α
vectors the performance of the d2 × 250 bp vector was
even worse compared to the control vector (Figure 4C and
4D).
We then transduced the neural stem cell line RN33B with
increasing doses of lentiviral vectors (CMV.SIN, d2 × 250
bp.CMV and 1.2 kb.CMV) based on functional titer. At
low MOIs the difference in expression between control
vectors and insulator vectors was relatively small both
with regard to the number of GFP positive cells and the
fluorescence intensity (Figure 4E–F). However, at higher
MOIs the dose-response curve of the insulator vectors
reached plateau at a lower number of transduced cells and
lower fluorescence intensity (Figure 4E–F). As to why this
reduced expression is due to a block in the transduction
pathway remains uncertain, but nonetheless efficient
transduction and high levels of transgene expression from
these vectors seem difficult to achieve.
Discussion
The original intention of this study was to analyse the
effects of a chromatin insulator on transgene expression
when inserted into lentiviral vectors. The idea was to use
a set-up that was independent of any type of selection and
that would allow us to study potential insulator effects in
cells with multiple integrants. Up to date most studies
using insulator sequences in retroviral or lentiviral set-
tings have relied on drug selection of transgene expressing
cells[19,28,31]. Furthermore, most studies have been
designed so that only cells with single copy integrants
have been analysed[18,19,32,33]. Such settings have little
in common with clinical gene therapy protocols. In order
to perform a non-selection based experiment we decided
to titer the vectors using real-time PCR on DNA from
transduced cells. This protocol has the advantage that it
does not rely on transgene expression in order to quantify
the titer of the vector preparation and allows a non-biased
quantification of integrating particles. When using stand-
ard lentiviral vectors without or with only one insulator
element we found highly reproducible results with this
non-selection based strategy. However, when we tried to
apply our non-biased strategy onto vectors containing two
separated copies of the cHS4 insulator in the reversed
transcribed form, we found that the DNA titration led to
overestimation of the titer, supposedly because of the for-
mation of secondary structure that is incompatible with
efficient transduction. This block appears to take place in
a step during transduction that is after reverse transcrip-
tion but before integration. How this block of integration
is established is unknown but it is possible that potential
secondary structures, caused by the double copies of the
insulator, impede proper formation and function of the
pre-integration complex (PIC) e.g. by preventing correct
alignment of the integrase to the integrase binding sites or
by hampering proper trafficking of the viral genome to the
nucleus after infection. However, several recent reports
demonstrate efficient transgene expression from non-inte-
grating lentiviral vectors present as classical 1-LTR or 2-
LTR circles[34,35]. These studies describe long-term
expression in post-mitotic cells at levels comparable to
integrating vectors. Since we show reduced expression
from double copy insulator vectors, the non-integrated
vector copies that we demonstrate must exist in a different
form incompatible with transgene expression.
These results have important consequences for the use of
insulator sequences in lentiviral vectors. It has been sug-
gested that insulators need to be present in double or
more copies in order to be fully functional[36,37]. This
has led to the suggestion that insulators form a loop-struc-
ture that is resistant to influences from surrounding chro-
matin. However, lentiviral and retroviral vectors carrying
such double copies have been reported by several groups
to be produced in low titer[15,19-22]. As we demonstrate
in this study that phenomenon is due to a block during
the infectious process, and, importantly, this seems to pre-
vent efficient transduction. When target cells were trans-
duced with increasing doses of vector, the resulting dose-
response curve reached a plateau at a lower number of
transduced cells and with a markedly reduced mean fluo-
rescence compared to control vectors. This suggests that
efficient transduction of difficult target cells such as pri-
mary cells will be compromised with this kind of insula-BMC Biotechnology 2009, 9:13 http://www.biomedcentral.com/1472-6750/9/13
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tor vectors, which will hamper their use in both ex vivo
and in vivo gene therapy settings.
We and others have seen only a modest effect on trans-
gene expression when using insulators in lentiviral vec-
tors[14,19,21]. On the contrary, there appears to be strong
positive effects when using more simple retroviral vectors
such as those based on MLV[18,28,33], and it is likely that
the effects of an insulator will be dependent on the con-
text, i.e. MLV contra lentiviral vectors. MLV-based and len-
tiviral vectors have different integration patterns. While
MLV vectors preferentially integrate near the promoter
region, the HIV-based vectors appear to integrate into the
entire intragenic region[38,39]. It is not certain how these
differences in integration sites affect transgene expression
or the appearance of insertional mutagenesis. However,
recent experiments in a tumorigenic mouse model show
that self-inactivating lentiviral vectors have low genotoxic-
ity compared to LTR-driven MLV vectors suggesting an
enhanced safety profile of such lentiviral vectors[40]. Fur-
thermore, lentiviral vectors appear to escape transgenic
silencing more efficiently than MLV vectors. An example
of this is the establishment of transgenic animals using
lentiviral vectors[41], although several examples of lenti-
Expression data of the d2 × 250 bp vectors Figure 4
Expression data of the d2 × 250 bp vectors. (A-D) Flow cytometric data for the transduction of naïve RN33B cells with 
d2 × 250 bp vectors and controls at MOI 1 and 5 (functional titer). Cells were analysed 7 days after transduction. The percent-
age of GFP-positive cells is shown (A and C) along with the mean fluorescence (MFU) (B and D). Error bars denote standard 
deviations. E-F: Dose-response curves showing CMV.SIN, d2 × 250 bp.CMV and 1.2 kb.CMV vector performance in naïve 
RN33B cells. The percentage of GFP positive cells (E) and mean fluorescence is shown (F).
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viral silencing in the generation of transgenic animals
have also been reported[42].
Other  cis-elements that have successfully been used to
enhance transgene expression from lentiviral vectors have
been identified, e.g. scaffold or matrix attachment regions
(SAR, MAR or S/MARs). These are A+T rich elements that
have been suggested to be involved in the anchoring of
the chromatin to the nuclear scaffold resulting in the for-
mation of chromatin loops thereby avoiding gene silenc-
ing[43,44], and elements that have shown to prevent
transgene silencing in a lentiviral context have been
derived from the human interferon-β gene, the human
immunoglobulin μ heavy-chain locus, the immunoglob-
ulin κ, etc[19,45,46]. Furthermore, the use of S/MAR in
combination with insulators have been shown to be
highly effective in enhancing transgene expression from
lentiviral vectors[19,47]. However, the effect of the S/MAR
elements appears, in most cases, to be tissue specific (for
review see[48]), which limits their general application,
and identification of S/MAR elements active in neural
cells will be important for gene therapeutic applications
in the brain. Improving lentiviral vector characteristics
with insulators or other cis-elements is therefore still an
area of interest.
Conclusion
In conclusion our results demonstrate that insulator
sequences can be incorporated into lentiviral vectors
either in the LTR or flanking the transgene cassette. How-
ever, when double copies are used these vectors have a
reduced functionality due to a block during the infectious
process, and consequently such vectors transduce target
cells poorly. Therefore, a careful analysis of the optimal
design must be performed before insulators are included
into clinical lentiviral vectors. Furthermore, it still remains
to be proven that insulator sequences actually improve
the safety profile of lentiviral vectors.
Methods
Transfer plasmids
The 250 bp core element of the cHS4 insulator was ampli-
fied from plasmid pJC5-4 (kindly provided by G. Felsen-
feld, Laboratory of Molecular Biology, National Institute
of Diabetes and Digestive Kidney Diseases, National Insti-
tute of Health, Bethesda) by four PCR-reactions using the
following PCR-reaction: 3 min at 95°C followed by 30
cycles of 30 sec at 95°C, 45 sec at 55°C and 90 sec at
72°C. Primers were designed according to Chung et
al.[25] and contained additional restriction sites (ClaI,
KpnI and MluI) making it possible to join two 250 bp core
elements into a 500 bp doublet where each core element
was situated in the same direction. Primers were as fol-
lows: Kpn up: 5'-GGT ACC GGA GCT CAC GGG GAC
AGC-3' Kpn down: 5'-GGT ACC CCT AAA GCT TTT TCC
CCG TA-3' Cla up: 5'-ATC GAT GGA GCT CAC GGG GAC
AGC-3' Cla down: 5'-ATC GAT CCT AAA GCT TTT TCC
CCG TA-3' Mlu up: 5'-ACG CGT GGA GCT CAC GGG
GAC AGC-3' and Mlu down: 5'-ACG CGT CCT AAA GCT
TTT TCC CCG TA-3'. Two doublets were generated: One
was flanked by KpnI-sites whereas the other was flanked
by ClaI-sites. These two fragments were then cloned in the
sense orientation into the ClaI and the KpnI-sites of pHR-
CMV.GFP.W (CMV.SIN) (kind gift from D. Trono,
Lausanne, Switzerland) and pHR-EF1α.GFP.W
(EF1α.SIN) (kindly provided by N.B. Woods, Lund, Swe-
den) using standard cloning procedures to generate pHR-
2 × 250 bp.CMV.GFP.W.2 × 250 (d2 × 250 bp.CMV) and
pHR-2 × 250 bp.EF1α.GFP.W.2 × 250 (d2 × 250
bp.EF1α). In addition a vector containing only one insu-
lator doublet was constructed (pHR-2 × 250.CMV.GFP.W,
s2 × 250 bp.CMV). The vector pHR-CMV.GFP.W.1.2 kb
(1.2 kb.CMV) has been described elsewhere and was only
modified by the addition of the cPPT fragment[21].
Lentiviral vectors were produced as described previ-
ously[4]. Briefly, transfer plasmids were co-transfected
with pMD.G and pBRΔ8.91 into 293T-cells, supernatants
were collected on days 3 and 4 and concentrated by ultra-
centrifugation. Viral vector preparations were not treated
with DNAse during the production step, since this has
been shown not to influence the functional titer or the rel-
ative DNA titers[49] (and unpublished observations). We
also excluded different levels of contaminating plasmid
DNA in the various vector preparations by performing
real-time PCR directly on concentrated viral vector stocks
and found no difference between the plasmid content of
control vectors compared to insulator vectors (P = 0.52,
data not shown). All results were reproduced with several
independently produced viral batches.
Determination of viral titer
Functional titers of vector preparation were assessed by
transduction of 100,000 cells (293T) with serial dilutions
of vector stocks. A dilution resulting in less than 10%
GFP-positive cells was used for determining the functional
titer of each vector. Each vector was titrated against the
control vectors CMV.SIN or EF1α.SIN.
Relative DNA titers were assessed by transduction of
50,000 cells (293T) with serial dilutions of vector stocks.
After 72 h cells were collected and lysed and subjected to
Taqman PCR[21] using the following primers LV2-F: 5'-
ACT TGA AAG CGA AAG GGA AAC-3', LV2-R: 5'-CAC
CCA TCT CTC TCC TTC TAG CC-3' LV2-Probe: 5'-Fam-
AGC TCT CTC GAC GCA GGA CTC GGC-Tamra-3'. All
samples were analysed in triplicates. Using the compara-
tive CT-method (userbulletin#2, http://www.appliedbio
systems.com) the relative DNA-titers were calculated in
relation to the control vectors, CMV.SIN and EF1α.SIN. ByBMC Biotechnology 2009, 9:13 http://www.biomedcentral.com/1472-6750/9/13
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definition the relative DNA-titer of CMV.SIN and
EF1α.SIN equalled their determined functional titer.
Cell culturing, transduction, flow cytometric analyses and 
determination of proviral load
293T cells and K562 were cultured at 37°C in humidified
atmosphere and 5% CO2  in DMEM and RPMI 1640
respectively. Media was supplemented with L-glutamine
and 10% foetal bovine serum. RN33B and HiB5 cells were
cultured and differentiated as described elsewhere[50].
Cells were transduced simply by applying the appropriate
amount of viral stock solution directly to the media of cell
cultures.
Flow cytometric analyses were performed as described by
Jakobsson et al[21]. Proviral loads of analysed cell cul-
tures were determined by real-time PCR. Briefly, cells were
harvested and lysed in 18 μl 50 mM Tris-HCl, pH 8.2
(Amresco), 100 mM NaCl (Merck), 5 mM EDTA (Chemi-
con) and 0.5% SDS (Chemicon). After addition of 2 μl
proteinase K (10 mg/ml, Gibco BRL) samples were incu-
bated at 55°C for 30 minutes. 200 μl of water was added
and samples were boiled for 10 minutes. Proviral load was
assessed by real-time PCR using the LV2 primer (above) in
reference to endogenous genes (the IL-2 gene in rat cells
and the albumin, ALB, gene in human cells). Sequences of
the IL-2 and albumin primers are: IL-2 Forward, 5'-GCC
TTG TGT GTT ATA AGT AGG AGG C-3', IL-2 Reverse, 5'-
AGT GCC AAT TCG ATG ATG AGC-3', IL-2 Probe, 5'-Fam-
TCT CCT CAG AAA TTC CAC CAC AGT TGC TG-Tamra-3',
ALB Forward, 5'-TGA AAC ATA CGT TCC CAA AGA GTT
T-3', ALB Reverse, 5'-CTC TCC TTC TCA GAA AGT GTG
CAT AT-3' and ALB Probe, 5'-Fam-TGC TGA AAC ATT
CAC CTT CCA TGC AGA-Tamra-3'.
Testing vector integrity
Quantitative real-time PCR was performed on cell lysates
28 days after infection as described above. Primers target-
ing a viral sequence (LV2, see above), GFP, WPRE and 1.2
kb insulator (INS) were used. Sequences of primers and
probes were: GFP Forward, 5'-ACT ACA ACA GCC ACA
ACG TCT ATA TCA-3, GFP Reverse, 5'-GGC GGA TCT TGA
AGT TCA CC-3', GFP Probe, 5'-Fam-CGA CCA GCA GAA
GAA CGG CAT CA-Tamra-3', WPRE Forward, 5'-CCG TTG
TCA GGC AAC GTG-3', WPRE Reverse, 5'-AGC TGA CAG
GTG GTG GCA AT-3', WPRE Probe, 5'-Fam-TGC TGA
CGC AAC CCC CAC TGG T-Tamra-3', INS Forward, 5'-
ACC GCT CTT TGG AGA AGG TAA A-3', INS Reverse, 5'-
ATG AGA GAT AAT GGC CTT ACG TTG T-3', and INS
Probe, 5'-Fam-CTT GCT AAA TCC AGC CCG ACC CTC C-
Tamra-3'. Standard curves for each primer pair were con-
structed and the abundance of each sequence was calcu-
lated using the comparative Ct method, taking into
account the efficiency of each primer set according to
Pfaffl (2001)[51]. All primer pairs used for real-time PCR
were validated and showed efficiencies above 90%.
Statistics
All experiments were performed in triplicate and repeated
in two independent experimental rounds and with inde-
pendently produced viral batches. Flow cytometry and
qPCR analyses were subjected to analysis of variance
(ANOVA) using SAS software followed by Tukey's HSD
when appropriate.
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